Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AARTIDRUGS | NSE
-4.65
-0.88%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
525.30
531.90
531.90
522.00
Aarti Drugs Limited through its subsidiaries engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories including anti-inflammatory cardioprotectants antidiarrhoeals antifungals antiarthritis/osteoporosis antibiotics antidiabetics Alzheimer's treatment sedatives vitamins and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole celecoxib ciprofloxacin clopidogrel diclofenac ketoconazole nimesulide and raloxifene. It also offers specialty chemical products such as benzene sulphonamide benzene sulphonic acid benzene sulphonic acid methyl ester benzene sulphonyl chloride cipro Q acid levofloxacin Q acid methyl nicotinate N-methyl methane sulphonamide diphenyl sulphone norofloxacin Q acid ofloxacin Q acid ortho para toluene sulphonamide ortho/para toluene sulphonic acid methyl ester para chloro benzene sulphonamide para chloro benzene sulphonyl chloride para toluene sulphonamide para toluene sulphonic acid methyl ester para toluene sulphonyl chloride and sodium benezene sulfinate as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate bisphenol " C bisphenol "" C(chloride) ethyl nicotinate ethyl para toluene sulphonate and N-methyl imidazole. In addition the company's products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Further it offers contract manufacturing services. The company was incorporated in 1984 and is headquartered in Mumbai India."
View LessNegative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
15.0%1 month
40.7%3 months
33.0%6 months
31.5%28.55
-
3.78
0.44
0.23
16.85
2.15
-
3.02B
48.30B
577.64M
0.19
9.49
-30.00
-16.00
13.87
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
63.65
Range1M
140.25
Range3M
142.95
Rel. volume
0.14
Price X volume
52.30M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 86.77 | 47.55B | -2.44% | 40.71 | 3.42% |
Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 380.5 | 46.92B | -4.35% | 72.22 | 68.84% |
Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 653.4 | 46.23B | -0.86% | n/a | 10.48% |
Sequent Scientific Limited | SEQUENT | Drug Manufacturers-Specialty & Generic | 177.85 | 44.41B | 0.01% | 774.74 | 74.28% |
Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 399.15 | 40.03B | -0.46% | 46.93 | 62.51% |
Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 143.65 | 36.89B | -1.84% | 14.02 | 0.42% |
RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 2174.75 | 36.30B | -2.27% | 43.29 | 0.00% |
Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 370.1 | 34.24B | -1.33% | 46.10 | 60.54% |
Suven Life Sciences Limited | SUVEN | Drug Manufacturers-Specialty & Generic | 155.78 | 33.97B | -0.85% | n/a | 0.26% |
SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 742.9 | 32.02B | -0.01% | n/a | 107.90% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
V2 Retail Limited | V2RETAIL | Apparel Retail | 1148.3 | 39.72B | 0.06% | 133.29 | 191.28% |
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 183.46 | 27.05B | -1.24% | 29.68 | 43.67% |
Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 31.55 | 27.02B | -4.54% | 82.05 | 10.74% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 229.62 | 23.62B | 0.79% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 16.85 | - | Cheaper |
Ent. to Revenue | 2.15 | - | Cheaper |
PE Ratio | 28.55 | 47.84 | Cheaper |
Price to Book | 3.78 | 6.55 | Cheaper |
Dividend Yield | 0.19 | - | Poor |
Std. Deviation (3M) | 32.98 | - | Par |
Debt to Equity | 0.44 | 0.34 | Expensive |
Debt to Assets | 0.23 | 0.17 | Expensive |
Market Cap | 48.30B | - | Emerging |